Member Info for bignose58

Bunions post was on the 16th April 2018. Interestingly, Recordati also mentioned Tunisia and Turkey to follow. Total population for the listed remainder of E11 yet to be launched (incl UK and Tunisia and Turkey) = 245mill which is about the same as the E5.

The.Italian and MR
Not wanting to put a damper on ur precise time scales statements, but the original launches Recordati quoted (by the same person) to bunion were Sept 2018 and Dec 2018 (Dec was then changed to Jan 2019. (You can read back through bunions posts to find it). Hence my apprehension on any new dates they have quoted. Once bitten twice shy as they say.

You are both right regarding the mc which as you both state should be multiples and anywhere else and probably at another time in HK, it would be. My feeling fwiw is that given the company has let the market down so often on all things related on time scales, the hk market has no trust. Hopefully other license agreement announcements will bring that trust back. As you say the china agreement should have had the sp at least double if not triple it's current value. The reaction was about a 10 to 15% which is paltry given its significance.

We now just have to sit tight and hope some other license agreements are forthcoming (which JG alluded to me a week or so ago would be soon). We still have had no explination why those agreements went back from "head of terms" (LOI) 2 years ago to "at an advanced stage". Given there was a statement about a link to eu sales, makes me think they have lost their excitement, which have probably come from the continous US delays. Just my opinion.

Montezrevenge,

You are certainly right there, but then. Since a promise is a declaration of something to shareholders or a shareholder etc, then it can be considered as reneging. Anyway, the pont is they, like RP, are not following their statements of timed events.

Since the transfer of marketing etc to Recordati, RP has no longer any say in the matter. What is more interesting is whether RP is keeping tabs on what Recordati are doing. Surely there has to be some continued follow up. And although you are correct that RP don’t need to keep the market or shareholders updated, they did make the statement on follow up launches in h2 of 2018 which was made at the same time as the disappointing sales statement.

It seems to me that they are not following up and probably appreciate the news from outside that launches have been delayed from those stated. I Honestly thought after all these years things would now be different as the product is out there. Apparently not and shareholders are again left to wonder what’s going on. As stated, the UK launch may get even further delayed since credibility on launch dates is now questionable.

Anyway, I await any response from JG who I am sure will provide a perfectly good explanation..... ;-)

Morning The.Italian.

Thanks for the feedback.

Exactly what I hypothesised that Recordati would delay further EU launches due to their "dissapontment in sales". What were to be Greece, Romania in Sept 2018 and Czech rep, Slovakia & Poland in Dec/Jan 2019 are now delayed indefinitely (since they can provide no dates). Interestingly they now state that the UK will be relaunched in Jan ....... Or will it ? I guess they cannot really say since they have now "reneged" on the other 5 EU launch dates.

Will this delay possibly impact progressing the ROW licenses since wasn't it announced that the ROW licenses would depend on the EU launches or am I miss quoting ?

Although the delays don't surprise me, it certainly contradicts the statement made in the unaudited interims announcement. "The Group is continuing to work closely with Recordati towards the planned commercialisation of
Fortacin™ in Greece, Romania, Czech Republic, Slovak Republic and Poland in the second half of 2018"

I have emailed JG for clarification since he surely is not aware otherwise he would have advised the market........"NOT"...lol

Bothwell,

Maybe this is the turning point. With a major Chinese license now in play which is far larger than the Recordati one with a huge population size, maybe investors are starting to take notice and realise the significance. Its going to be a continued spread of information which should be exponential. I am sure those that get in now will not regret it.

The.Italian,

I too used that form and had a response from Marianne Tatschke who I understand is in charge of investor relations.

My response email came from here => investorelations@recordati.it , which you could try and email directly and address to the above. I would suggest you state you also have a small holding in Recordati. No proof of purchase is required..... ;-)

The.Italian,

Interesting since they normally do respond (Did you mention you held shares in both Recordati and RPG. ;-) ).

Maybe the launches have not happened given that their contribution is small (Romania 2.5mill and Greece 1.4 mill => 1 in 4 male sufferers), which I alluded to after the announcement of Recordati being disappointed. I guess we will find out in the year end results which should also include Poland/Czech Rep and Slovakia.

The.Italian....hear what ? Mind you, I did just read something about it....LOL

Finally, the https://clinicaltrials.gov/ct2/show/NCT03578783 website is now showing "Recruiting". Onwards and upwards.

I think you mean Mr Mellon since JG was brought onboard after the event.

I definitely hope so...........

Trouble is after all that's gone before, one just has to reign in and go with the most pessimistic possibility. Even the market seems to have taken that stance too....... LOL.

Anyway, I must admit I am more hopeful there will be one or two more license announcements before that since that's all that's left to do...... ;-)

Apparently the FDA asked for a change of protocol so recruitment was moved to Dec. The overall delay is about 8 weeks so immaterial for the approval process. Still expect an NDA PDUFA date in 2021.

That is indeed true and I have written so earlier, however. That is purely speculation and we know where speculation has gotten us so far..... nowhere. What I wrote recently was based on what the company has factually stated and until we actually see something to change that, that's all we have got to go on.... no ?

Matt

Theyve bin in the pipeline for the last 4 years. 2 years ago they were at heads of terms (LOI). 2 years ago China wasn't even gg to be considered. Yet here we are with a China agreement n nothing else new.

The question is what's happened to all the others and what have they been working on apart from China for the last 2 years ? Doesn't quite make sense does it. Particularly since the Latin American licensee was near biting Jamie's arm off 2 years ago......lol

No sales income for between 3 to 5 years, so currently as useful as a fart in a spacesuit ... :-)

Although initial licensing payments may negate the need for a cash call next year, however, it has been alluded that further agreements are on the horizon, we will just have to wait and see.

Next to no value attributed to that announcement then...... :-)

I guess it's still a case of no trust or faith in the company.

With yesterday's sells and so far today, it makes one wonders who the sellers are ? Are they traders just looking for a 5 to 10% gain from the few weeks ago lows. What was it 36mill yesterday and 5.5mill so far today. I'm sure there were not that many buys in the lows ? And there surely cannot be that many share holders with that many shares with a low average now left ?

Not impatience, just a bad stutter.....LOL

Matt

Correct me if I am wrong, but I am pretty sure that was a conglomerate of several buys (and could even include sells). Orders put in last night or early this morning. I don't think the system picks them up separately since they are non AMS. I write this since very often there are indicated dealings pre-open and are identified as "Other"
.
However, I agree with your statement on triggered sells since many, me included, were not expecting anything till next year since incorrectly I was under the impression that the PRC licensee would also market the product in HK and Macau which were reported as not being marketed till early 2019 (I am sure many others were under this impression too), which obviously is not the case. There must be many who stil are not aware of the new agreement, so yes we could see some rise over the next few days........................famous last words if past announcements and market reaction are anything to go by...... LOL.

Mind you, it is a biggie wrt the bigger picture and could very well attract more long term investors before take-off..... :-)

True, although more sells than buys. I guess traders selling out from buying in at the lows. And certainly no big ticket holders climbing aboard, which could mean they all got in following the UK launch announcement ?

I understand more news to come early next year, so just sit tight and ride the waves.... ;-)

Hopefully the local investors will read between the lines and conclude that no licensee would probably sign an agreement with another 3 to 5 year wait. The sp should then reflect the potential value of a sooner approval ... :-)